About Cavidi
Cavidi was founded in 1984 by two virologists from Uppsala University in Sweden. The company’s initial focus was the application of reverse transcriptase in the in vitro detection of biomarkers for oncology and infectious diseases. Thus the name CAVIDI — CAncer and VIrus DIagnostics. The company succeeded in developing tests that could rival PCR in sensitivity, yet required no specialized equipment or workflows.
In 2020 the team at Cavidi was following the pandemic closely and wanted to help. They felt their expertise in virology, biomarkers, and RT could be relevant to the global crisis.
Cavidi’s research focus shifted to address the global pandemic. Managing the SARS-CoV-2 virus requires an easily deployed diagnostic test. Virologists at Cavidi set out to provide results that could rival the accuracy of PCR without the cost, equipment, or time required to run the test.
What started as the pursuit of a fast, easy, and reliable way to diagnose COVID-19 ended with the discovery of BOLD (Binding Oligo Ladder Detection) — a novel immunoassay signal booster that can be used to increase the sensitivity of virtually any type of immunoassay by a factor of up to 100x with minimal background noise. Branded Exazym®, it was successfully trialled on the SARS-CoV-2 virus and is now being tested on a number of challenging low-abundance biomarkers.
Exazym® is a game-changer in biomarker detection and precision health. It makes highly reliable, incredibly sensitive detection accessible to all researchers globally.
The company is now fully focused on bringing Exazym® and BOLD to a global audience through direct sales of kits and services to researchers as well as forging licensing agreements with research-use-only (RUO) kit providers and partnerships with companies providing various in-vitro diagnostic (IVD) applications for use in hospitals and clinics.
Products
Exazym® is a game-changer in biomarker detection and precision health. It makes highly reliable, incredibly sensitive detection accessible to all researchers globally.
Sectors
- kits
- molecular
- custom services